Indian companies have committed a record $20.5 billion investment in the US, with over 90% ($19.1B) focused on the pharmaceutical sector. This strategic move, announced at an investment summit, aims to create thousands of jobs and advance the bilateral goal of doubling US-India trade to $500 billion by 2030. For exam aspirants, this highlights India's growing economic diplomacy and outward foreign direct investment (OFDI) trends, a key topic in Economy and International Relations.
Exam Lens
Quick Exam Facts From News
1-Minute Revision
- ›Total Investment Pledged: $20.5 billion
- ›Pharma Sector Investment: $19.1 billion
- ›Target this Data: $20.5 billion total pledged investment; $19.1 billion for pharmaceuticals.
- ›Target this Nodal Body: US Embassy (as the announcing entity) and the participating Indian companies (Sun Pharma, Aurobindo, etc.).
- ›Target this Legal Point: The strategic bilateral goal to double US-India trade to $500 billion by 2030.
Mastered this topic? Test your knowledge with a full MCQ quiz.
Practice exam-style questions, track your score, and strengthen your recall.